What is the longest someone has lived with MBC?

What is the longest someone has lived with MBC?

Rita Arditti: Lived over 30 years with MBC.

Can you live 10 years with MBC?

Currently, more than one-quarter of patients diagnosed with MBC can expect to survive at least five years, and some live more than 10 years. Moreover, the rapid emergence of novel therapies continues to increase survival rates and improve quality of life.

Can MBC go into remission?

While metastatic breast cancer may not go away completely, treatment may control it for a number of years. If one treatment stops working, there usually is another you can try. The cancer can be active sometimes and then go into remission at other times.

Is MBC curable?

While treatable, metastatic breast cancer (MBC) cannot be cured. The five-year survival rate for stage 4 breast cancer is 22 percent; median survival is three years. Annually, the disease takes 40,000 lives.

Do metastatic cancer patients have the same questions and experiences?

After speaking to cancer patients and cancer patient advocates, it’s clear that no matter where the origin of the cancer, metastatic cancer patients share similar questions and experiences. Find metastatic cancer stories from patients below.

What is metastatic cancer?

Dr. Shayne: As you alluded to, it is cancer that has spread from the site of disease origin. For example in breast cancer, breast cancer can metastasize to or spread to areas such as the lungs, the liver, bones and brain most commonly.

Who is Kelly Guenther’s cancer survivor?

I’m your host and cancer survivor, Kelly Guenther. Joining us is Deb Violette. Deb is a 10-year cancer survivor. She was diagnosed with stage IIIA non-small cell lung cancer and was given a 10 percent chance of living two years.

How long did Debdeb live with cancer?

Deb is a 10-year cancer survivor. She was diagnosed with stage IIIA non-small cell lung cancer and was given a 10 percent chance of living two years. Currently, she is a lung cancer life advocate and also serves as a patient advocate for the Dartmouth-Hitchcock Oncology Board clinical trial in Maine.